Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for kids with Tough-to-Treat leukemia

NCT ID NCT04925479

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study is testing a medicine called asciminib in children and teenagers (ages 1 to 18) with a specific type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia. The main goal is to find the right dose for kids and check its safety, especially for those whose cancer didn't respond well to previous treatments. Researchers are enrolling about 44 participants and will follow them for up to 5 years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, PHILADELPHIA POSITIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Childrens Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104 4399, United States

    Contact Phone: •••-•••-••••

    Contact

  • Cinn Children Hosp Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229-3039, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Columbia University Medical Center New York Presbyterian

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-••••

    Contact

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Indiana UH Riley H for CIU

    RECRUITING

    Indianapolis, Indiana, 46202-5167, United States

    Contact Email: •••••@•••••

    Contact

  • Novartis Investigative Site

    RECRUITING

    Hangzhou, Zhejiang, 310052, China

  • Novartis Investigative Site

    RECRUITING

    Beijing, 100044, China

  • Novartis Investigative Site

    RECRUITING

    Shanghai, 200127, China

  • Novartis Investigative Site

    RECRUITING

    Tianjin, 300020, China

  • Novartis Investigative Site

    RECRUITING

    Bordeaux, 33076, France

  • Novartis Investigative Site

    RECRUITING

    Lille, 59000, France

  • Novartis Investigative Site

    RECRUITING

    Paris, 75019, France

  • Novartis Investigative Site

    RECRUITING

    Poitiers, 86021, France

  • Novartis Investigative Site

    RECRUITING

    Erlangen, 91054, Germany

  • Novartis Investigative Site

    RECRUITING

    Essen, 45147, Germany

  • Novartis Investigative Site

    RECRUITING

    Hamburg, 20246, Germany

  • Novartis Investigative Site

    RECRUITING

    Athens, 115 27, Greece

  • Novartis Investigative Site

    RECRUITING

    Budapest, H-1083, Hungary

  • Novartis Investigative Site

    RECRUITING

    Genova, GE, 16147, Italy

  • Novartis Investigative Site

    RECRUITING

    Monza, MB, 20900, Italy

  • Novartis Investigative Site

    RECRUITING

    Roma, RM, 00165, Italy

  • Novartis Investigative Site

    RECRUITING

    Torino, TO, 10126, Italy

  • Novartis Investigative Site

    RECRUITING

    Yokohama, Kanagawa, 232-8555, Japan

  • Novartis Investigative Site

    RECRUITING

    Shinjuku-ku, Tokyo, 160 8582, Japan

  • Novartis Investigative Site

    RECRUITING

    Osaka, 534-0021, Japan

  • Novartis Investigative Site

    RECRUITING

    Utrecht, 3584 CS, Netherlands

  • Novartis Investigative Site

    RECRUITING

    Wroclaw, 50367, Poland

  • Novartis Investigative Site

    RECRUITING

    Moscow, 117198, Russia

  • Novartis Investigative Site

    RECRUITING

    Saint Petersburg, 197022, Russia

  • Novartis Investigative Site

    RECRUITING

    Seoul, 03080, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, 05505, South Korea

  • Novartis Investigative Site

    RECRUITING

    Khon Kaen, THA, 40002, Thailand

  • Novartis Investigative Site

    RECRUITING

    Bangkok, 10400, Thailand

  • Novartis Investigative Site

    RECRUITING

    Chiang Mai, 50200, Thailand

  • Novartis Investigative Site

    RECRUITING

    Istanbul, Fatih, 34093, Turkey (Türkiye)

  • Novartis Investigative Site

    RECRUITING

    Bursa, Nilufer, 16059, Turkey (Türkiye)

  • Uni Of Texas MD Anderson Cancer Ctr

    RECRUITING

    Houston, Texas, 77024, United States

    Contact Email: •••••@•••••

    Contact

  • University Of Utah

    RECRUITING

    Salt Lake City, Utah, 84132, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216-4505, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MYELOID LEUKEMIA, PHILADELPHIA POSITIVE